Nov 30, 2022 / 06:30PM GMT
Matthew Oliver O'Brien - Piper Sandler & Co., Research Division - MD & Senior Research Analyst
Thanks for joining us. I'm Matt O'Brien, I cover Medtech here at Piper. Really excited to have the Teleflex team here with us. They don't need an introduction. I'll provide one anyway.
We've got Liam, who's the CEO; and then Larry, who is the Head of IR, and then John is actually down in the audience as well. John, thanks so much for making the trip up. Appreciate it.
John Hsu - Teleflex Incorporated - VP of IR
Of course, thanks for having us.
Questions and Answers:
Matthew Oliver O'Brien - Piper Sandler & Co., Research Division - MD & Senior Research AnalystYou bet so going into -- we're going to get into UroLift, I swear at some point. But I did want to start off with maybe some other areas of the market, a little bit of the business just to maybe change things up, I'm sure, a little bit from what you're customers talking about.
But talk a little
Trustpilot
